TO STUDY THE THE EFFECT OF MUSTAKATUKA CHURNA IN RASIED LIPID LEVELS

Phase 2/3

Not yet recruiting

• Conditions: Other disorders of lipoprotein metabolism. Ayurveda Condition: rasa raktagat medo dushti ,

• Registration Number: CTRI/2022/02/040171
• Lead Sponsor: Dr Akanksha Dandekar

Brief Summary

The present study is the clinical experimental study for completion under D.Y.Patil deemed to be University

Total duration of trials is 1 years



TITLE: Controlled study of Mustakatuka churna in rasa raktagat medo dushti w.s.r. yo dyslipidemia



STUDY GROUP: Sample size 30 will be treated with Mustakatuka churna and 30 will be treated with Atorvastatin



STUDY CENTRE: School of Ayurveda D.Y.Patil Deemed to be University Nerul, NaviMumbai.



PG SCHOLAR: Dr. Akanksha Dandekar



GUIDE: Dr. Kalpana Satpute.

Detailed Description

Not available

Study Timeline

• Study Start: 2022-02-18
• Last Update Posted: 2022-04-02

Recruitment & Eligibility

• Status: Not Yet Recruiting
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

• newly diagnosed dyslipidemia patients Lipid Panel: SR.
• LIPID PANEL BORDERLINE 1 Total Cholesterol 200 to 293 mg/dl 2 LDL-C 130 to 159 mg /dl 3 HDL-C 35 to 45 mg/dl 4 Triglycerides 150-199 mg/dl.

Exclusion Criteria

• Age: <30, >75yrs Pregnant women & lactating mothers. Patients having history of serious cardiac disorders like myocardial infarction, cardiac failure, COPD. Untreated thyroid disorder. Patients having any major illness like uncontrolled diabetes mellitus. Known case of Asthma, neurological disorders, anemia (Hb<10mg/dl). Known case of Renal insufficiency, nephrotic syndrome. Known case of severe Liver diseases. Known case of HIV positive and HbsAg positive patients. Immune compromised patients. Any serious medical and psychological condition subjects will not be included. Blood Lipid profile according to NCEP -According to Adult Treatment Panel SR. NO. LIPID PANEL DESIRABLE HIGH RISK 1 Total Cholesterol < 200 mg /dl >240 mg/dl 2 LDL-C > 130mg/dl 160-189 mg/dl 3 HDL-C.
• Female < 40 mg/dl < 50 mg/dl 4 Triglycerides >150 mg/dl 200-499 mg/dl.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Controlled study of MustaKatuka churna in rasa raktagat medo dushti w.s.r. to Dyslipidemia	0 to 45 days

Secondary Outcome Measures

Name	Time	Method
To study the efficacy of mustakatuka churna in management of dyslipidemia	To study the effects of Atorvastatin

Trial Locations

Locations (1)

Dr D.Y.Patil School of Ayurveda,; 🇮🇳 Thane, MAHARASHTRA, India

Dr D.Y.Patil School of Ayurveda,

🇮🇳Thane, MAHARASHTRA, India

Dr Akanksha Dandekar

Principal investigator

9637998998

dr.akankshadandekar@gmail.com